Glaxo settles U.S. drug pricing complaint (Reuters)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20050920/hl_nm/glaxosmithkline_settlement_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/rids/20050920/i/r325372515.jpg?x=130&y=86&sig=vcUoebX7E7EYQykMrYwbZw--" align="left" height="86" width="130" alt="Drugmaker GlaxoSmithKline has paid more than $150 million to settle government charges that the company fraudulently inflated the price of drugs purchased by federal health-care programs, the U.S. Justice Department said on Tuesday. Shown is the GlaxoSmithKline corporate headquarters in Brentford, Middlesex, United Kingdom. REUTERS/Handout" border="0" /></a>Reuters - GlaxoSmithKline has paid more than
$150 million to settle government charges that the company
fraudulently inflated the price of drugs purchased by federal
health-care programs, the U.S. Justice Department said on
Tuesday.</p><br clear=all>